Sigma HealthcareASX:SIG +2.20%59 PS Ratio is 1.17 as of Jul. 03, 2026, which is 516% above its 10-year median of 0.19. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 116 Medical Distribution companies, Sigma Healthcare ranks worse than 76.72% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sigma Healthcare's share price is A$2.79.
Sigma Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$2.38. Hence, Sigma Healthcare's PS Ratio for today is 1.17.
The historical rank and industry rank for Sigma Healthcare's PS Ratio or its related term are showing as below:
ASX:SIG'
s PS Ratio Range Over the Past 10 Years
Min: 0.12 Med: 0.19 Max: 1.19
Current: 1.19
During the past 13 years, Sigma Healthcare's highest PS Ratio was 1.19. The lowest was 0.12. And the median was 0.19.
ASX:SIG's PS Ratio is ranked worse than 76.72% of 116
companies
in the Medical Distribution industry
Industry Median: 0.415
vs ASX:SIG: 1.19
Sigma Healthcare Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Sigma Healthcare was -15.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -3.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -0.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -0.10% per year.
During the past 13 years, Sigma Healthcare's highest 3-Year average Revenue per Share Growth Rate was 55.60% per year. The lowest was -10.20% per year. And the median was 3.90% per year.
Back to Basics: PS Ratio
Sigma Healthcare (ASX:SIG) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sigma Healthcare PS Ratio Related Terms
Sigma Healthcare PS Ratio Historical Data
* Premium members only.
The historical data trend for Sigma Healthcare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sigma Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma Healthcare PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sigma Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sigma Healthcare's Share Price of today is A$2.79.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sigma Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$2.38.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sigma Healthcare (ASX:SIG) has a PS Ratio of 1.17 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sigma Healthcare and its competitors. This is 516% above median its historical median of 0.19. Over the past decade, Sigma Healthcare's PS Ratio has ranged from 0.12 to 1.19. According to the industry distribution chart, Sigma Healthcare ranks #89 out of 116 companies in the Medical Distribution industry, placing it in the top 76.7%.
Is Sigma Healthcare's PS Ratio too high?
Sigma Healthcare's current PS Ratio of 1.17 is 516% above median its 10-year median of 0.19. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 1.19. The Medical Distribution industry median PS Ratio is 0.42. Sigma Healthcare's value of 1.17 is 181.9% above this industry median. Based on the distribution chart, Sigma Healthcare ranks #89 out of 116 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's PS Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #89 out of 116 companies for PS Ratio. This places Sigma Healthcare in the lower half of its industry. The industry median PS Ratio is 0.42. Sigma Healthcare's value of 1.17 is 181.9% above this benchmark. Historically, Sigma Healthcare's own PS Ratio has ranged from 0.12 to 1.19 over the past decade. While the company's 10-year median is 0.19 vs. the industry median of 0.42, Sigma Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.42, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigma Healthcare's current PS Ratio of 1.17 is 181.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sigma Healthcare and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current PS Ratio is 1.17, which is 516% above median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.79 — trading 654.1% above its estimated fair value. The current PS Ratio is 1.17, which is 516% above median its 10-year median of 0.19 and 181.9% above the Medical Distribution industry median of 0.42. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current PS Ratio is 1.17 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?
Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued.
The current stock price of A$2.79 is trading 654.1% above its estimated GF Value™ of A$0.37.
GuruFocus considers Sigma Healthcare to be Significantly Overvalued.
Key valuation signals for ASX:SIG:
PS Ratio: 1.17 (516% above median its 10-year median of 0.19)
GF Value™: A$0.37 vs. price of A$2.79 (654.1% above fair value)
Industry Position: 181.9% above the Medical Distribution median (#89 of 116)
No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score
Get the complete analysis for ASX:SIG
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SIG has been successfully added to your 
